Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced the one-year anniversary of TYSABRIÃ?® (natalizumab) as a treatment for relapsing forms of multiple sclerosis (MS). [click link for full article]
From: www.medicalnewstoday.com
Tysabri® Celebrates One-Year Anniversary As A Treatment For Multiple Sclerosis
Posted by Ruslan Abuzant at 2:38 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment